A company based in Charlotte, North Carolina, has products that comply with FDA guidelines.
2 reports, 1 independent
Updated Jul 17
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A company based in Charlotte, North Carolina, has products that comply with FDA guidelines.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Ricoh's division amassed diverse FDA clearances and helped open an AM Center of Excellence while spinning off the business unit.Sub-event
- NeoGenomics gained FDA approval for an IHC companion diagnostic test in North Carolina, which identifies patients eligible for targeted therapy.Sub-event
Products of cbdMD, Inc. comply with FDA guidelines and the company is based in Charlotte, North Carolina.1 source
Keep exploring
The entities involved
- FDA
-
North Carolina
state of the United States of America
Related events
- FDA approval enables commercial opportunity involving CBRE Group.
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
- A product was launched in the U.S. market following FDA involvement.
- Charlie's Holdings, Inc. has begun the process of seeking favorable regulatory status for its products with the FDA and has launched them across the state of California.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.